期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment 被引量:26
1
作者 Clayton M Spiceland nilesh lodhia 《World Journal of Gastroenterology》 SCIE CAS 2018年第35期4014-4020,共7页
Endoscopy plays a fundamental role in the diagnosis, management, and treatment of inflammatory bowel dis-ease(IBD). Colonoscopy, flexible sigmoidoscopy, and esophagogastroduodenoscopy have long been used in the care o... Endoscopy plays a fundamental role in the diagnosis, management, and treatment of inflammatory bowel dis-ease(IBD). Colonoscopy, flexible sigmoidoscopy, and esophagogastroduodenoscopy have long been used in the care of patients with IBD. As endoscopic technologies have progressed, tools such as endoscopic ultrasound, capsule endoscopy, and balloon-assisted enteroscopy have expanded the role of endoscopy in IBD. Furthermore, chromoendoscopy has enhanced our ability to detect dys-plasia in IBD. In this review article, we will focus on the roles, indications, and limitations of these tools in IBD. We will also discuss the most commonly used endoscopic scoring systems, as well as special considerations in post-surgical patients. Lastly, we will discuss the role of endoscopy in the diagnosis and management of fistulae and strictures. 展开更多
关键词 ENDOSCOPY Inflammatory bowel DISEASE Crohn’s DISEASE ULCERATIVE colitis Colonoscopy Capsule ENDOSCOPY DYSPLASIA detection STRICTURE dilation Fistula MANAGEMENT
下载PDF
Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis 被引量:9
2
作者 nilesh lodhia Michael Kader +2 位作者 Thalia Mayes Parvez Mantry Benedict Maliakkal 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第12期1459-1464,共6页
AIM:To evaluate the incidence of contrast-induced nephropathy(CIN)in cirrhotic patients and to identify risk factors for the development of CIN.METHODS:We performed a retrospective review of 216 consecutive patients w... AIM:To evaluate the incidence of contrast-induced nephropathy(CIN)in cirrhotic patients and to identify risk factors for the development of CIN.METHODS:We performed a retrospective review of 216 consecutive patients with cirrhosis who underwent computed tomography(CT)with intravenous contrast at the University of Rochester between the years 2000-2005.We retrospectively examined factors associated with a high risk for CIN,defined as a decrease in creatinine clearance of 25%or greater within one week after receiving contrast.RESULTS:Twenty-five percent of our patients developed CIN,and 74%of these patients had ascites seen on CT.Of the 75%of patients who did not develop CIN,only 46%had ascites.The presence of ascites was a significant risk factor for the development of CIN(P=0.0009,OR 3.38,95%CI 1.55-7.34)in multivariate analysis.Patient age,serum sodium,Model for End-stage Liver Disease score,diuretic use,and the presence of diabetes were not found to be significant risk factors for the development of CIN.Of the patients who developed CIN,11%developed chronic renal insufficiency,defined as a creatinine clearance less than baseline for 6 wk.CONCLUSION:Our results suggest that in hospitalized cirrhotic patients,especially those with ascites,the risk of CIN is substantial. 展开更多
关键词 ASCITES CIRRHOSIS Contrast-inducednephropathy Renal failure
下载PDF
Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth:A retrospective study of 932 patients 被引量:4
3
作者 Richard A Schatz Qing Zhang +3 位作者 nilesh lodhia Jonathan Shuster Phillip P Toskes Baharak Moshiree 《World Journal of Gastroenterology》 SCIE CAS 2015年第15期4574-4582,共9页
AIM: To investigate, in the largest cohort to date, patient characteristics and associated risk factors for developing small intestinal bacterial overgrowth(SIBO) using the D-Xylose breath test(XBT).METHODS: We perfor... AIM: To investigate, in the largest cohort to date, patient characteristics and associated risk factors for developing small intestinal bacterial overgrowth(SIBO) using the D-Xylose breath test(XBT).METHODS: We performed a retrospective crosssectional study to analyze patient characteristics who underwent the XBT for evaluation of SIBO. Diagnostic testing with the XBT was performed based on a clinical suspicion for SIBO in patients with symptoms of bloating, abdominal pain, abdominal distension, weight loss, diarrhea, and/or constipation. Consecutive electronicmedical records of 932 patients who completed the XBT at the University of Florida between 2005 and 2009 were reviewed. A two-way Analysis of Variance(ANOVA) was used to test for several associations including age, gender, and body mass index(BMI) with a +XBT. A two-way ANOVA was also performed to control for the differences and interaction with age and between genders. A similar analysis was repeated for BMI. Associations between medical conditions and prior surgical histories were conducted using the Mantel-Haenszel method for 2 by 2 contingency tables, stratified for gender. Reported odds ratio estimates reflect the odds of the prevalence of a condition within the +XBT group to that of the-XBT group. P values of less than 0.05(two-sided) were considered statistically significant.RESULTS: In the 932 consecutive eligible subjects studied, 513 had a positive XBT. A positive association was found between female gender and a positive XBT(P = 0.0025), and females with a positive test were, on average, greater than 5 years older than those with a negative test(P = 0.024). The mean BMI of positive XBT subjects was normal(24.5) and significantly lower than the subjects with a negative XBT(29.5)(P = 0.0050). A positive XBT was associated with gastroesophageal reflux disease(GERD)(OR = 1.35; 95%CI: 1.02-1.80, P = 0.04), peptic ulcer disease(PUD)(OR = 2.61; 95%CI: 1.48-4.59, P < 0.01), gastroparesis(GP)(OR = 2.04; 95%CI: 1.21-3.41, P < 0.01) and steroid use(OR = 1.35; 95%CI: 1.02-1.80, P = 0.01). Irritable bowel syndrome, independent protonpump inhibitor(PPI) usage, or previous abdominal surgery was not significantly associated with a positive XBT. No single subdivision by gender or PPI use was associated with a significant difference in the odds ratios between any of the subsets. CONCLUSION: Female gender, lower BMI, steroid use, PUD, GERD(independent of PPI use), and GP were more prevalent in patients with SIBO, determined by a positive XBT. Increasing age was associated with SIBO in females, but not in males. 展开更多
关键词 INTESTINE Small IRRITABLE bowel syndrome XYLOSE BREATH tests Proton pump inhibitors GASTROPARESIS Bacteria
下载PDF
Hepatic portal venous gas due to cryptosporidiosis in a patient with acquired immunodefi ciency syndrome
4
作者 nilesh lodhia Atif Ali Joel Bessoff 《World Journal of Hepatology》 CAS 2010年第11期406-409,共4页
Although the presence of hepatic portal venous gas (HPVG) on computed tomography (CT) is typically an ominous finding, HPVG may sometimes be less catastrophic. The clinical significance of HPVG is variable, and it dep... Although the presence of hepatic portal venous gas (HPVG) on computed tomography (CT) is typically an ominous finding, HPVG may sometimes be less catastrophic. The clinical significance of HPVG is variable, and it depends primarily on the underlying pathol ogy. We report a case of a patient with acquired immunodeficiency syndrome (AIDS) who was found to have HPVG on CT as a presumed result of gastrointestinal cryp tosporidiosis, an association that, to our knowledge, has not been reported. This case illustrates another cause of HPVG that should be considered in patients with AIDS. 展开更多
关键词 HEPATIC PORTAL VENOUS gas CRYPTOSPORIDIOSIS ACQUIRED immunodef iciency SYNDROME
下载PDF
Updates in therapeutic drug monitoring in inflammatory bowel disease
5
作者 nilesh lodhia Shanti Rao 《World Journal of Gastroenterology》 SCIE CAS 2022年第21期2282-2290,共9页
Biologics and immunomodulators(IMM)are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn’s disease.However,despite the efficacy of these therapies,many patients eithe... Biologics and immunomodulators(IMM)are generally considered the most effective therapies for the treatment of ulcerative colitis and Crohn’s disease.However,despite the efficacy of these therapies,many patients either have a primary lack of response or a secondary loss of response to these medications.Therapeutic drug monitoring(TDM)is a systematic approach to managing such patients.In this review,we summarize the latest data on TDM,including reactive and proactive TDM,in patients with inflammatory bowel disease on biologics and/or IMM. 展开更多
关键词 Inflammatory bowel disease Therapeutic drug monitoring Crohn’s disease Ulcerative colitis
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部